SCHEMBL1686908

SCHEMBL1686908

Cc1cccc(C)c1[Si](O)(O)c1c(C)cccc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
CYP2A6 P11509 2/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.42
ACHE P22303 1/20 0.42
TRPA1 O75762 2/20 0.42
ATM Q13315 2/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CD44 P16070 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1686634 0.82 ALDH1A1 (0.48) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL1686540 0.74 TRPA1 (0.35) CYP2A6CYP1A2TSHRTRPA1ATM
SCHEMBL1686911 0.71 ALDH1A1 (0.44) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL7048579 0.71 CYP2A6 (0.43) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL7053223 0.71 CA1 (0.48) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL1314842 0.71 CYP2A6 (0.43) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL5031009 0.71 CYP2A6 (0.43) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL16707379 0.71 CYP2A6 (0.43) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL1686698 0.70 TRPA1 (0.48) ALDH1A1CYP2A6CYP1A2TSHRACHE
SCHEMBL1313561 0.69 CYP2A6 (0.41) ALDH1A1CYP2A6CYP1A2TSHRACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932330-B2 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-26 US disclosed
US-7592402-B2 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-09-22 US disclosed
US-20080319148-A1 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2008-12-25 US disclosed
US-7115539-B2 Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2006-10-03 US disclosed
US-20050245701-A1 Process for producing modified particle; carrier; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2005-11-03 US disclosed
US-20040209762-A1 Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209762-A1 Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer AP1M1, PYM1, SEM1 ALDH1A1 1378/4885CYP2A6 3512/4885CYP1A2 2200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.